Latest News and Press Releases
Want to stay updated on the latest news?
-
Peer-Reviewed Study Conducted in Collaboration with Mayo Clinic Demonstrates 100% Sensitivity and Strong Predictive Power for Esophageal Cancer Progression Early Access Programs and Physician...
-
Study Acceptance Supports and Provides the Catalyst for Upcoming Commercial Rollout and Revenue-Generating Potential UNIONDALE, NY, Oct. 22, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ:...
-
SAN FRANCISCO, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Researchers conducted a comprehensive and systematic review of mobile cognitive training apps and published their peer-reviewed findings ranking the...
-
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
-
First characterization of its novel conjugation technology for creating stable, well-defined ADCs with linkers that enable payload attachment to native, unmodified antibodies at a universally...
-
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
-
IRVINE, Calif., March 16, 2022 (GLOBE NEWSWIRE) -- Designed to plant thoughts and grow dreams. Introducing the Margaret Jeane for Blue Sky planner collection, a fresh collaboration stemming from a...
-
Golden, CO, Nov. 17, 2020 (GLOBE NEWSWIRE) -- A new material for wind blades that can be recycled could transform the wind industry, rendering renewable energy more sustainable than ever before...
-
ZURICH, Switzerland, June 07, 2019 (GLOBE NEWSWIRE) -- The Flow Chemistry Society has named Dr. Timothy Noel from Eindhoven University of Technology as the new Editor in Chief of Journal of Flow...
-
Emotional health/self-perception issues were most common; limitations of lifestyle and activities as well as coping strategies were also important Provectus Biopharmaceuticals expands pivotal Phase 3...